全文获取类型
收费全文 | 2945篇 |
免费 | 196篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 89篇 |
妇产科学 | 36篇 |
基础医学 | 334篇 |
口腔科学 | 48篇 |
临床医学 | 356篇 |
内科学 | 475篇 |
皮肤病学 | 88篇 |
神经病学 | 279篇 |
特种医学 | 97篇 |
外科学 | 387篇 |
综合类 | 383篇 |
一般理论 | 2篇 |
预防医学 | 210篇 |
眼科学 | 20篇 |
药学 | 190篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 140篇 |
出版年
2022年 | 43篇 |
2021年 | 77篇 |
2020年 | 38篇 |
2019年 | 79篇 |
2018年 | 100篇 |
2017年 | 49篇 |
2016年 | 66篇 |
2015年 | 87篇 |
2014年 | 133篇 |
2013年 | 151篇 |
2012年 | 153篇 |
2011年 | 133篇 |
2010年 | 149篇 |
2009年 | 122篇 |
2008年 | 134篇 |
2007年 | 115篇 |
2006年 | 123篇 |
2005年 | 90篇 |
2004年 | 102篇 |
2003年 | 67篇 |
2002年 | 80篇 |
2001年 | 58篇 |
2000年 | 48篇 |
1999年 | 63篇 |
1998年 | 47篇 |
1997年 | 50篇 |
1996年 | 45篇 |
1995年 | 23篇 |
1994年 | 36篇 |
1993年 | 20篇 |
1992年 | 32篇 |
1991年 | 23篇 |
1990年 | 31篇 |
1989年 | 48篇 |
1988年 | 40篇 |
1987年 | 31篇 |
1986年 | 30篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 20篇 |
1982年 | 37篇 |
1981年 | 17篇 |
1980年 | 23篇 |
1977年 | 18篇 |
1976年 | 16篇 |
1974年 | 19篇 |
1973年 | 21篇 |
1972年 | 18篇 |
1971年 | 15篇 |
1927年 | 15篇 |
排序方式: 共有3148条查询结果,搜索用时 15 毫秒
91.
Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells 总被引:9,自引:0,他引:9
Finstad HS; Kolset SO; Holme JA; Wiger R; Farrants AK; Blomhoff R; Drevon CA 《Blood》1994,84(11):3799-3809
Promyelocytic leukemic HL-60 cells were incubated with different fatty acids. Arachidonic acid (AA; 20:4, n-6) and eicosapentaenoic acid (EPA; 20:5, n-3) were the most potent inhibitors of proliferation in a dose- dependent way. Retinoic acid (RA) was used as a positive control. Inhibitors of cyclooxygenase and lipoxygenase or addition of antioxidants did not influence the effect of EPA or AA on cell proliferation. Increased capacity to generate superoxide anions after phorbol ester treatment and a reduced serglycin messenger RNA level in cells treated with AA or EPA indicated that these fatty acids induced differentiation in HL-60 cells similar to that induced by RA. However, down-regulation of the c-myc mRNA level, also typical for differentiation with RA in HL-60 cells, was not observed in cells incubated with AA or EPA. Flow cytometric analyses showed that in cultures incubated with AA or EPA, the proportion of cells in the G1 phase of the cell cycle increased. Similar effects were observed with RA. By flow cytometry and light scatter analyses it could be shown that AA made 8% of the cells apoptotic and 7% necrotic. The corresponding numbers were 21% and 10% for RA-treated cells, and 19% and 32% for EPA- treated cells. The present study shows that AA and EPA reduce the proliferation rate of HL-60 cells. This is mediated by mechanisms independent of eicosanoids or lipid peroxidation products and is due to effects both on apoptosis/necrosis and cell differentiation. 相似文献
92.
Diarrhoea and weight loss are frequently reported adverse events in rheumatoid arthritis (RA) patients receiving the disease-modifying antirheumatic drug (DMARD) leflunomide. According to the available literature these side effects occur mostly during the first 6 months of treatment, are rather mild and rarely lead to treatment withdrawal. In this report, we describe the clinical, endoscopic and histologic findings in two RA patients with severe diarrhoea and important weight loss more than 12 months after starting treatment with leflunomide. In both cases the symptoms were caused by colitis, but one had ulcerative and the other microscopic colitis. Despite treatment with budesonide the complaints only improved after withdrawal of leflunomide, making a causal relationship between this drug and the pathogenesis of colitis probable. The heterogeneous histopathological findings in these two patients, however, do not allow us to draw any definitive conclusions about the mechanism by which leflunomide causes diarrhoea and weight loss in RA patients. We conclude that persistent diarrhoea or weight loss in patients taking leflunomide can be more serious than what is previously reported in the literature. In such cases leflunomide treatment should be stopped and an endoscopic examination of the colon is recommended. Given the long half-life of this drug a washout procedure with cholestyramine should be considered whenever the problem is severe or persistent. 相似文献
93.
Arrhythmogenic Evidence for Epicardial Adipose Tissue: Heart Rate Variability and Turbulence are Influenced by Epicardial Fat Thickness 下载免费PDF全文
94.
95.
96.
97.
Shiva K. Annamalai Michele L. Esposito Lena Jorde Theodore Schreiber Shelley A. Hall William W. ONeill Navin K. Kapur 《Journal of cardiac failure》2018,24(10):706-710
Background
Myocarditis complicated by cardiogenic shock remains a complex problem. The use of acute mechanical circulatory support devices for cardiogenic shock is growing. We explored the utility of Impella transvalvular microaxial flow catheters in the setting of myocarditis with cardiogenic shock.Methods and Results
We retrospectively analyzed data from 21 sites within the cVAD registry, an ongoing multicenter voluntary registry at sites in North America and Europe that have used Impella in patients with myocarditis. Myocarditis was defined by endomyocardial biopsy (n?=?11) or by clinical history without angiographic evidence of coronary disease (n?=?23). A total of 34 patients received an Impella 2.5, CP, 5.0, or RP device for cardiogenic shock complicating myocarditis. Baseline characteristics included age 42 ± 17 years, left ventricular ejection fraction (LVEF) 18% ± 10%, cardiac index 1.82 ± 0.46 L·min?1·m?2, pulmonary capillary wedge pressure 25 ± 7 mm Hg, and lactate 27 ± 31 mg/dL. Before Impella placement, 32% (n?=?11) of patients required intra-aortic balloon pump. Mean duration of Impella support was 91 ± 74 hours; 21 of 34 patients (62%) survived the index hospitalization and were discharged with an improved mean LVEF of 37.32% ± 20.31% (P?=?.001); 15 patients recovered with successful support, 5 patients were transferred to another hospital on initial Impella support, 1 patient underwent orthotopic heart transplantation. Ten patients required transition to another mechanical circulatory support device.Conclusions
This is the largest analysis of Impella-supported myocarditis cases to date. The use of Impella appears to be safe and effective in the settings of myocarditis complicated by cardiogenic shock. 相似文献98.
Ayano Kelly Kathleen Tymms Maarten de Wit Susan J. Bartlett Marita Cross Therese Dawson Mary De Vera Vicki Evans Michael Gill Geraldine Hassett Irwin Lim Karine Manera Gabor Major Lyn March Sean ONeill Marieke Scholte-Voshaar Premarani Sinnathurai Daniel Sumpton Armando Teixeira‐Pinto Peter Tugwell Bart van den Bemt Allison Tong 《Arthritis care & research》2020,72(10):1410-1419
99.
100.
Sex differences in anxiety and depression clinical perspectives 总被引:1,自引:0,他引:1
Sex differences are prominent in mood and anxiety disorders and may provide a window into mechanisms of onset and maintenance of affective disturbances in both men and women. With the plethora of sex differences in brain structure, function, and stress responsivity, as well as differences in exposure to reproductive hormones, social expectations and experiences, the challenge is to understand which sex differences are relevant to affective illness. This review will focus on clinical aspects of sex differences in affective disorders including the emergence of sex differences across developmental stages and the impact of reproductive events. Biological, cultural, and experiential factors that may underlie sex differences in the phenomenology of mood and anxiety disorders are discussed. 相似文献